GLP-1 drugsHumans33,161 participantsCohort study

Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial

Figure 1 from Metabolism — Figure 1Yen et al.

Metabolism

The paper

Fu‐Shun Yen, Pei‐Lun Liao, Yao-Min Hung,

Chih-Cheng Hsu, Chinsu Liu, Ming‐Chih Hou, Chii‐Min Hwu,

James Cheng-Chung Wei

Dr. Yen's Clinic · China Medical University

Metabolism · 29 Sep 2026

doi.org/10.1016/j.metabol.2026.156790 PubMed 42810614

SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
Low-carb telemedicine links to fewer cardiovascular events
Cardiology and Therapy · 4 Oct 2026